Acomplia is the trade name of rimonabant (generic name), which has been approved in the European Union (EU), Argentina, and Mexico for the treatment of obesity. As of March 2007, rimonabant (the proposed U.S. trade name is Zimulti) is under review ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles